Challenges Facing the Pharmaceutical Industry

  • Date: 27 March 2014
  • Author: John La Mattina, former President, Pfizer Global R&D
  • Published: 03 March 2014
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
1437c26f628.jpg

Register for this webinar


Challenges Facing the Pharmaceutical Industry

John LaMattina, former President, Pfizer Global R&D, discusses how and why the pharma industry is devalued and distrusted.



The seminar includes:
a) Challenges facing the industry: establishing the safety AND value of new drugs;

b) Issues facing the Industry on its reputation;

c) A prescription form restoring its reputation.

Webinar: Challenges Facing the Pharmaceutical Industry



Speaker


John La Mattina

former President, Pfizer Global R&D
Senior Partner at PureTech Health
and author of Drug Truths: Dispelling the Myths About Pharma R&D and Devalued and Distrusted: Can the Pharmaceutical Industry Restore its Broken Image?



► This webinar is available on-demand. It is free-to-view.
If you have already registered for this event, please login using the link provided in your registration confirmation email.
Otherwise, please use the registration link below.

► Free Registration

Those that attend the webinar will be entitled to a 30 % discount on either or both of John L. LaMattina’s books:
Drug Truths: Dispelling the Myths About Pharma R&D, and
Devalued and Distrusted: Can the Pharmaceutical Industry Restore its Broken Image?
.

(valid till April 30th)

Get your local time for the Webinar


Article Information

DOI: 10.1002/chemv.201400025

Article Views: 9372

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH